Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Clinical trial NCT05327023 · RECRUITING
Trial details
- NCT number
- NCT05327023
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2028-07-03
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.